Startups
JDRF is now Breakthrough T1D.
As we drive toward curing type 1 diabetes, we help make everyday life better for the people who face it. We are Breakthrough T1D.
As we drive toward curing type 1 diabetes, we help make everyday life better for the people who face it. We are Breakthrough T1D.
Overview
Location
United States, New York
Mentions in press and media 22
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 23, 2026 | Tidepool Receives Breakthrough T1D Research Grant To Develop Automated Insulin Delivery Technology Without Meal Announcements | Tidepool, a Palo Alto, California-based nonprofit developing diabetes management software, has received research funding from Breakthrough T1D to advance an automated insulin delivery algorithm designed to reduce the need for manual carbohy... |
| Oct 7, 2026 | Year-End Report 25/26 | Year-End Report 25/26 Wed, Oct 07, 2026 08:15 CET Report this content September 2025 – August 2026, Diamyd Medical AB (publ), Fiscal year 2025/2026 Financial summary (September 2025 – August 2026) Net sales: MSEK 0.5 (0.1), fourth quarter: ... |
| Aug 20, 2026 | Greenstone Biosciences Wins Breakthrough T1D Grant To Build Patient-Derived 3D Islet Platform With Multi-Omics | Greenstone Biosciences has received a Breakthrough T1D Industry Discovery and Development Partnership grant to develop a patient-derived islet cell platform aimed at improving understanding of insulin-producing beta cells in people with typ... |
| Aug 19, 2026 | Greenstone Biosciences Receives Breakthrough T1D Grant | Greenstone Biosciences, a Palo Alto, CA-based biotechnology company integrating AI-based drug discovery with clinical genomics and iPSC platforms, received a Breakthrough T1D grant. The amount of the deal was not disclosed. The company inte... |
| Mar 29, 2026 | Diamyd Medical updates on the interim efficacy analysis of Phase 3 DIAGNODE-3 trial | Diamyd Medical updates on the interim efficacy analysis of Phase 3 DIAGNODE-3 trial Sun, Mar 29, 2026 22:45 CET Report this content Diamyd Medical on Friday March 27th announced that the pre-specified interim efficacy analysis on 174 out of... |
| Mar 24, 2026 | Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study | Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study in type 1 diabetes CARY, N.C. and NEW YORK, March 24, 2026 /PRNewswire/ -- Continuity Biosciences and Breakthrough T1D, the leading globa... |
| Feb 24, 2026 | Diamyd Medical announces finalization of database for interim analysis in Phase 3 DIAGNODE-3 trial | Diamyd Medical announces finalization of database for interim analysis in Phase 3 DIAGNODE-3 trial Tue, Feb 24, 2026 08:45 CET Report this content The clinical database has been finalized for the pre-specified interim efficacy analysis in D... |
| Jan 13, 2026 | diaTribe Convenes International Consensus to Guide Diabetes Technology Use During Pregnancy | Expert recommendations provide crucial guidance to leverage CGM and AID during pregnancy. SAN FRANCISCO, Jan. 13, 2026 /PRNewswire/ -- The diaTribe Foundation announces the publication of the first international consensus statement on the u... |
| Jul 22, 2025 | Diamyd Medical releases the full video recording from a panel discussion at the ADA meeting in June | Diamyd Medical releases the full video recording from a panel discussion at the ADA meeting in June Tue, Jul 22, 2025 16:00 CET Report this content Diamyd Medical co-hosted, as previously announced, a high-impact panel discussion together w... |
Show more
Reviews 0
FAQ about Breakthrough T1D
What has the press written about Breakthrough T1D?
Parsers VC has collected 22 articles mentioning Breakthrough T1D, among them “Tidepool Receives Breakthrough T1D Research Grant To Develop Automated Insulin Delivery Technology Without Meal Announcements” (Oct 23, 2026) and “Year-End Report 25/26” (Oct 7, 2026).
Is Breakthrough T1D still active?
Breakthrough T1D is probably closed: its latest activity on Parsers VC dates from Nov 3, 2026.